Ptc Therapeutics PTCT
NASDAQ PTCT
$63.46 -0.67 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ptc Therapeutics (PTCT) Cash & Equivalents (2012 - 2026)

Updated

Ptc Therapeutics' Cash & Equivalents came in at $1.05 billion for Q2 2026, up 3.2% from $1.02 billion a year earlier and up 25.9% from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Cash & Equivalents (2012 - 2026) Analysis & Trends

At the end of FY2025, Ptc Therapeutics' Cash & Equivalents was $984.65 million, up 26.3% from FY2024.

  • Cash & Equivalents has increased in each of the last four years, with a five-year compound annual growth rate of 36.4% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $779.71 million in FY2024 (+31.3%), $594 million in FY2023 (+112.3%), $279.83 million in FY2022 (+47.5%) and $189.72 million in FY2021 (-9.1%).
  • The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q1 2025.
  • Year-over-year, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 61.1%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2024 (growth of 227.4%), and the weakest in Q3 2021 (a decline of 56.3%).
  • Business Quant data shows PTCT's Cash & Equivalents at $833.99 million (Q1 2026), $984.65 million (Q4 2025) and $672.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Ptc Therapeutics 5.34 Bn -2.41 Bn 340.60 Mn 1.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.05 Bn
Mar 31, 2026 833.99 Mn
Dec 31, 2025 984.65 Mn
Sep 30, 2025 672.62 Mn
Jun 30, 2025 1.02 Bn
Mar 31, 2025 1.48 Bn
Dec 31, 2024 779.71 Mn
Sep 30, 2024 526.00 Mn
Jun 30, 2024 654.78 Mn
Mar 31, 2024 548.36 Mn
Dec 31, 2023 594.00 Mn
Sep 30, 2023 165.16 Mn
Jun 30, 2023 208.39 Mn
Mar 31, 2023 167.50 Mn
Dec 31, 2022 279.83 Mn
Sep 30, 2022 104.42 Mn
Jun 30, 2022 158.16 Mn
Mar 31, 2022 144.18 Mn
Dec 31, 2021 189.72 Mn
Sep 30, 2021 189.82 Mn
API Access

Ptc Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTCT&period=max&api_key=YOUR_API_KEY